MRI-visible Perivascular Spaces in Cerebral Amyloid Angiopathy and Hypertensive Arteriopathy
Authors
Affiliations
Objective: To assess MRI-visible enlarged perivascular spaces (EPVS) burden and different topographical patterns (in the centrum semiovale [CSO] and basal ganglia [BG]) in 2 common microangiopathies: cerebral amyloid angiopathy (CAA) and hypertensive arteriopathy (HA).
Methods: Consecutive patients with spontaneous intracerebral hemorrhage (ICH) from a prospective MRI cohort were included. Small vessel disease MRI markers, including cerebral microbleeds (CMBs), cortical superficial siderosis (cSS), and white matter hyperintensities (WMH), were rated. CSO-EPVS/BG-EPVS were assessed on a validated 4-point visual rating scale (0 = no EPVS, 1 = <10, 2 = 11-20, 3 = 21-40, and 4 = >40 EPVS). We tested associations of predefined high-degree (score >2) CSO-EPVS and BG-EPVS with other MRI markers in multivariable logistic regression. We subsequently evaluated associations with CSO-EPVS predominance (i.e., CSO-EPVS > BG-EPVS) and BG-EPVS predominance pattern (i.e., BG-EPVS > CSO-EPVS) in adjusted multinomial logistic regression (reference group, BG-EPVS = CSO-EPVS).
Results: We included 315 patients with CAA-ICH and 137 with HA-ICH. High-degree CSO-EPVS prevalence was greater in CAA-related ICH vs HA-related ICH (43.8% vs 17.5%, < 0.001). In multivariable logistic regression, high-degree CSO-EPVS was associated with lobar CMB (odds ratio [OR] 1.33, 95% confidence interval [CI] 1.10-1.61, = 0.003) and cSS (OR 2.08, 95% CI 1.30-3.32, = 0.002). Deep CMBs (OR 2.85, 95% CI 1.75-4.64, < 0.0001) and higher WMH volume (OR 1.02, 95% CI 1.01-1.04, = 0.010) were predictors of high-degree BG-EPVS. A CSO-EPVS-predominant pattern was more common in CAA-ICH than in HA-ICH (75.9% vs 39.4%, respectively, < 0.0001). CSO-PVS predominance was associated with lobar CMB burden and cSS, while BG-EPVS predominance was associated with HA-ICH and WMH volumes.
Conclusions: Different patterns of MRI-visible EPVS provide insights into the dominant underlying microangiopathy type in patients with spontaneous ICH.
Lynch K, Custer R, Sepehrband F, Toga A, Choupan J bioRxiv. 2025; .
PMID: 40060450 PMC: 11888170. DOI: 10.1101/2024.10.14.616343.
Tsai H, Pasi M, Liu C, Tsai Y, Yen R, Chen Y J Stroke. 2025; 27(1):65-74.
PMID: 39916455 PMC: 11834354. DOI: 10.5853/jos.2024.02376.
Plasma Phosphorylated Tau 217 as a Discriminative Biomarker for Cerebral Amyloid Angiopathy.
Hsieh P, Tsai H, Liu C, Lee B, Tsai Y, Yen R Eur J Neurol. 2025; 32(2):e70066.
PMID: 39907306 PMC: 11795418. DOI: 10.1111/ene.70066.
Characterizing the underlying microangiopathy of deep cerebellar intracerebral hemorrhage.
Das A, Abramovitz Fouks A, Gokcal E, Rotschild O, Pasi M, Regenhardt R J Neurol. 2025; 272(2):167.
PMID: 39853492 DOI: 10.1007/s00415-025-12905-8.
Jensen-Kondering U, Hess K, Neumann A, Margraf N Biomolecules. 2024; 14(11).
PMID: 39595634 PMC: 11592298. DOI: 10.3390/biom14111459.